Houston, TX, March 10, 2010 OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced Pamela Westbrook as its new Contract Chief Financial Officer. Ms. Westbrook brings over 25 years of experience with a broad-based medical device background, including CFO roles at small and large companies, ranging from venture-backed start-up to publicly traded companies with market caps in excess of $1 billion.
AcceleDent is a simple, removable dental device that orthodontic patients wear in the mouth for 20 minutes daily to accelerate tooth movement. Last month, AcceleDent was introduced at the 7th International Orthodontic Congress (IOC) in Sydney, Australia, which is held by the World Federation of Orthodontists (WFO) every five years. The Company plans to begin shipment of commercial product to the Australian market in the second quarter.
Ms. Westbrook, who is a Texas certified public accountant, commented, “I am delighted to have the opportunity to work with the team at OrthoAccel. The company is well-positioned to provide a valuable product for orthodontic patients and I look forward to working closely with the management team and Board of Directors to advance the company’s business plan.”
OrthoAccel is presently controlling availability of AcceleDent in the United Kingdom to a select group of orthodontic specialists before a broader release in October 2010.
Michael Lowe, CEO of OrthoAccel, noted, “We met with a number of exceptional individuals about this position with OrthoAccel, and Pam clearly rose to the top. Within all of her experience and accomplishments, perhaps the most compelling talent that she brings is the ability to manage growth. We are very pleased to have her as a part of the team here.”
OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.
About OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.co.uk or requested via firstname.lastname@example.org
Media Contact Michael K. Lowe, CEO +1 (832) 631-1659